Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003
- PMID: 14749614
Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003
Abstract
Developmental disabilities (DDs) are chronic conditions that initially manifest in persons aged < or =18 years and result in impairment of physical health, mental health, cognition, speech, language, or self-care. The majority of persons with DDs require long-term supportive care or services. In 2003, RTI International (Research Triangle Park, North Carolina) and CDC analyzed data from multiple surveys and reports to estimate the direct and indirect economic costs associated with four DDs in the United States. On the basis of that analysis, estimated lifetime costs in 2003 dollars are expected to total 51.2 billion dollars for persons born in 2000 with mental retardation, 11.5 billion dollars for persons with cerebral palsy, 2.1 billion dollars for persons with hearing loss, and 2.5 billion dollars for persons with vision impairment. These estimates underscore the need for effective primary and secondary prevention measures (e.g., newborn screening for hearing and metabolic disorders and smoking-cessation counseling for pregnant women) to reduce the costs associated with DDs.
Similar articles
-
Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.Arthritis Rheum. 2004 Jul;50(7):2317-26. doi: 10.1002/art.20298. Arthritis Rheum. 2004. PMID: 15248233
-
The economic impact and cost of visual impairment in Australia.Br J Ophthalmol. 2006 Mar;90(3):272-5. doi: 10.1136/bjo.2005.080986. Br J Ophthalmol. 2006. PMID: 16488942 Free PMC article.
-
Economic costs of birth defects and cerebral palsy--United States, 1992.MMWR Morb Mortal Wkly Rep. 1995 Sep 22;44(37):694-9. MMWR Morb Mortal Wkly Rep. 1995. PMID: 7666849
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Dental care for individuals with developmental disabilities is expensive, but needed.J Calif Dent Assoc. 2002 Jun;30(6):427-32. J Calif Dent Assoc. 2002. PMID: 12519052 Review.
Cited by
-
Ultrasonic neuromodulation as a new therapy for spasticity in an animal model of spastic cerebral palsy.Acta Cir Bras. 2024 Aug 16;39:e394924. doi: 10.1590/acb394924. eCollection 2024. Acta Cir Bras. 2024. PMID: 39166555 Free PMC article.
-
Minimum effective dose of clemastine in a mouse model of preterm white matter injury.Pediatr Res. 2024 Sep;96(4):933-941. doi: 10.1038/s41390-024-03326-w. Epub 2024 Jun 28. Pediatr Res. 2024. PMID: 38942888 Free PMC article.
-
Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial.Front Psychiatry. 2024 May 14;15:1400621. doi: 10.3389/fpsyt.2024.1400621. eCollection 2024. Front Psychiatry. 2024. PMID: 38807685 Free PMC article.
-
Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.Orphanet J Rare Dis. 2024 May 19;19(1):205. doi: 10.1186/s13023-024-03214-w. Orphanet J Rare Dis. 2024. PMID: 38764027 Free PMC article.
-
The critical need to accelerate cerebral palsy research with consumer engagement, global networks, and adaptive designs.J Pediatr Rehabil Med. 2024;17(1):9-17. doi: 10.3233/PRM-240014. J Pediatr Rehabil Med. 2024. PMID: 38552123 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
